Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Nuvation Bio Inc has a consensus price target of $5.64 based on the ratings of 7 analysts. The high is $10 issued by Jefferies on March 27, 2024. The low is $2.5 issued by BMO Capital on August 2, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Wedbush, and RBC Capital on September 16, 2024, September 11, 2024, and August 6, 2024, respectively. With an average price target of $5.67 between HC Wainwright & Co., Wedbush, and RBC Capital, there's an implied 88.90% upside for Nuvation Bio Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Nuvation Bio (NYSE:NUVB) was reported by HC Wainwright & Co. on September 16, 2024. The analyst firm set a price target for $7.00 expecting NUVB to rise to within 12 months (a possible 133.34% upside). 15 analyst firms have reported ratings in the last year.
The latest analyst rating for Nuvation Bio (NYSE:NUVB) was provided by HC Wainwright & Co., and Nuvation Bio maintained their buy rating.
The last upgrade for Nuvation Bio Inc happened on March 27, 2024 when Jefferies raised their price target to $10. Jefferies previously had a hold for Nuvation Bio Inc.
The last downgrade for Nuvation Bio Inc happened on January 6, 2023 when Jefferies changed their price target from $5 to $2 for Nuvation Bio Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nuvation Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nuvation Bio was filed on September 16, 2024 so you should expect the next rating to be made available sometime around September 16, 2025.
While ratings are subjective and will change, the latest Nuvation Bio (NUVB) rating was a maintained with a price target of $8.00 to $7.00. The current price Nuvation Bio (NUVB) is trading at is $3.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.